Siegfried Kasper

Professor Emeritus of Psychiatry; former Chair of the Department of Psychiatry and Psychotherapy, Medical University of Vienna

Data updated

Papers

6 publications

Trials

0 clinical trials

Links

Research Footprint

Siegfried Kasper appears in 6 tracked papers (2015–2026), most studied alongside Ketamine and Esketamine, across Depressive Disorders, Suicidality and Treatment-Resistant Depression (TRD).

Most-cited paper: Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation (676 citations).

Frequent co-authors: Daniel Fu, William Drevets and Daniel Ionescu.

Background & Research

Siegfried Kasper is an Austrian psychiatrist and psychotherapist born in Salzburg in 1950. He served as Professor and Chair of Psychiatry and Psychotherapy at the Medical University of Vienna and retired in 2019, continuing scientific work in translational neuroscience. His research spans affective disorders, psychopharmacology, and neuroimaging, and he has been recognized with major honors for his contributions to biological psychiatry.

Key Impact

A highly cited psychiatrist whose work has helped shape modern evidence and expert guidance for ketamine and esketamine in depression, suicidality, and treatment-resistant illness.

6

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

20 collaborators· click a node to visit their profile

Full network →

Affiliations

Institutions, companies, and organisations Siegfried Kasper is associated with.